tris(2-carboxyethyl)phosphine has been researched along with alpha-synuclein in 1 studies
Studies (tris(2-carboxyethyl)phosphine) | Trials (tris(2-carboxyethyl)phosphine) | Recent Studies (post-2010) (tris(2-carboxyethyl)phosphine) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
---|---|---|---|---|---|
266 | 1 | 145 | 10,821 | 29 | 8,011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, R; Hameed, R; Nazir, A; Pal, HA; Verma, S | 1 |
1 other study(ies) available for tris(2-carboxyethyl)phosphine and alpha-synuclein
Article | Year |
---|---|
Controlled release of hydrogen sulfide significantly reduces ROS stress and increases dopamine levels in transgenic C. elegans.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Antioxidants; Caenorhabditis elegans; Dopamine; Drug Liberation; Hydrogen Sulfide; Oxidation-Reduction; Oxidative Stress; Peptides; Phosphines; Prodrugs; Reactive Oxygen Species; Thiones; Thiophenes | 2019 |